A California federal jury on Wednesday ordered Medtronic's CoreValve unit to pay nearly $106.5 million to plaintiff Colibri Heart Valve in an infringement dispute involving a medical device used for replacing heart valves that is less invasive than open-heart surgery, finding that Medtronic actively induced infringement of the claims in Colibri's patent.
By Blake Brittain (Reuters) - A unit of medical device maker Medtronic plc must pay $106.5 million to competitor Colibri Heart Valve LLC for patent in.
In the changed post COVID-19 business landscape, the global market for Transcatheter Pulmonary Valves estimated at US$65. 5 Million in the year 2020, is.
Overall demand for prosthetic valves is projected to grow at a prolific CAGR of 11.4% totaling US$ 36.3 Bn during the forecast period of 2022-32 | Key